Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Net Cash Flow (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Net Cash Flow readings, the most recent being $10.7 million for Q1 2026.

  • Quarterly Net Cash Flow rose 206.5% to $10.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.1 million through Mar 2026, up 200.51% year-over-year, with the annual reading at -$13.7 million for FY2025, 138.14% down from the prior year.
  • Net Cash Flow hit $10.7 million in Q1 2026 for Oric Pharmaceuticals, up from -$4.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $44.7 million in Q2 2023 and bottomed at -$113.4 million in Q1 2022.
  • Average Net Cash Flow over 5 years is -$10.0 million, with a median of -$5.6 million recorded in 2024.
  • The largest annual shift saw Net Cash Flow tumbled 540.04% in 2022 before it soared 631.74% in 2024.
  • Oric Pharmaceuticals' Net Cash Flow stood at $37.8 million in 2022, then plummeted by 107.56% to -$2.9 million in 2023, then soared by 631.74% to $15.2 million in 2024, then plummeted by 126.35% to -$4.0 million in 2025, then surged by 368.24% to $10.7 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Net Cash Flow are $10.7 million (Q1 2026), -$4.0 million (Q4 2025), and -$26.2 million (Q3 2025).